Africa Pharmaceutical & Biotechnology Market Size By Application(Drug Formulations Industry, Biotechnology Industry, Active Pharmaceutical Ingredients (API) Industry) And Forecast

Africa Pharmaceutical & Biotechnology Market Size And Forecast

Africa Pharmaceutical & Biotechnology Market size was valued at USD 73,413.12 Million in 2022 and is projected to reach USD 138,221.16 Million by 2030, at a CAGR of 8.24% from 2023 to 2030.

The rapid urbanization of Africa is a significant element pushing the growth of the pharmaceutical and biotechnology markets across the continent. The Africa Pharmaceutical & Biotechnology Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

What is Pharmaceutical & Biotechnology?

Biotechnology is a significant component of the healthcare system. Biotechnology is widely employed in the production of different medications and vaccines that are used to treat a variety of disorders. Pharmaceutical and biotechnology firms offer their consumers cost-saving solutions since doing business with environmentally friendly vendors may eventually lead to reduced rates. Also, they can shorten the time needed for managing and running a production and research facility. Services for outsourcing also assist businesses in breaking down trade barriers and more readily entering international markets.

Pharmaceutical and biopharmaceutical expenditures in innovative therapies like synthetic biology are fueling R&D activities as well as drug development services. Increased demand has led to the development of service offerings by contract research organizations (CROs) and contract manufacturing organizations (CMOs) for biotechnology and pharmaceuticals. Increasing CRO investment for the growth of essential skills and growing R&D spending by pharmaceutical firms for the development of potential innovative medicines are expected to boost the market in the area in the years ahead.

In the biotechnology and pharmaceutical sectors, government restrictions are crucial. Standards for medication efficacy and safety are established by the FDA and other regulatory agencies, and they influence the price and duration of the drug development process. The way pharmaceuticals are designed, evaluated, and administered is changing as a result of new technologies such as gene editing, artificial intelligence, and precision medicine. These advancements are being used by biotech and pharmaceutical businesses to speed up the drug development process and provide more specialized and individualized treatments.

Africa Pharmaceutical & Biotechnology Market Overview

Africa's booming cities are a major force behind the growing pharmaceutical and biotech industries there. The continent's population is shifting fast! Just think, by 2025, about 30 cities with over two million residents will be responsible for two-fifths of Africa's economic growth. And get this22 of those cities will have economies worth more than USD 20 billion. Life in the city means better transportation, improved healthcare, and families with more money who are more open to using modern medicines. In fact, Africa is urbanizing faster than anywhere else on Earth, clocking in at 3.2% per year – way above the global average of 2%. Right now, around 472 million people live in African cities, and experts predict that number will jump to 810 million by 2035!

It's no secret that non-communicable illnesses (NCDs) are on the rise in South Africa. In fact, the World Health Organization (WHO) reports that these illnesses are responsible for a whopping 71% of all deaths in the country! What's driving this trend? Well, a lot of it comes down to things like eating unhealthy meals, not getting enough exercise, smoking cigarettes, and drinking too much alcohol. But it's not all bad news. The South African government is taking steps to tackle this issue, with policies aimed at promoting healthy lifestyles, making healthcare more accessible, and putting restrictions on harmful products like tobacco and alcohol. Ultimately, getting a handle on NCDs in South Africa is going to require everyone working together – the government, healthcare professionals, civil society, and individuals – to encourage healthy habits, steer clear of those risk factors, and ensure that people living with NCDs get the treatment and support they need.

So, the pharmaceutical and biotech market is really taking off, and that's because of everything we just talked about. But here's the thingin Africa, governments and private groups often don't have a ton of cash to throw at research and development. This could make it harder to train and support life scientists. Also, African countries might not have the top-notch research stuff needed for life science studies, like well-equipped labs and all the fancy gadgets. On a brighter note, the South African government stepped up and created the South African Medical Study Council, which is all about boosting health research and development in the country. They've been key players in tackling COVID-19, from studies to creating diagnostic tools and treatments. Similarly, Kenya has the Kenya Medical Study Institute (KEMRI), which dives into studies on human, animal, and environmental health. KEMRI's been a big deal in coming up with vaccines and treatments for diseases like malaria and HIV/AIDS.

Africa Pharmaceutical & Biotechnology MarketSegmentation Analysis

The Africa Pharmaceutical & Biotechnology Market is segmented on the basis of Application.

Africa Pharmaceutical & Biotechnology Market, By Application

• Drug Formulations Industry
• Biotechnology Industry
• Active Pharmaceutical Ingredients (API) Industry

To Get Summarized Market Report By Application-

In 2022, the drug Formulations Industry, categorized by Application, led the market with a whopping 52.80% share, translating to a USD 38,759.09 Million valuation. Experts predict a 7.39% CAGR growth for this segment. Following closely was the Biotechnology Industry, which held the second-largest market position in 2022 with a USD 26,283.57 Million value and is expected to grow at an 8.99% CAGR. Interestingly, the Active pharmaceutical ingredients (API) Industry is forecasted to experience the most rapid growth, boasting a 9.58% CAGR. The African Drug Formulations Industry plays a crucial role in bolstering the continent’s healthcare system. This industry focuses on developing finished pharmaceutical products, or formulations, to combat various diseases and ailments. While many African nations are still developing their industries and remain largely dependent on imported formulations, countries like South Africa, Egypt, and Morocco have established pharmaceutical sectors. These countries produce a diverse range of drug formulations for domestic use and export to neighboring regions.

The African biotechnology market? It's just getting started, really, but it's got room to grow like crazy in the coming years! What's fueling all this? Well, people want better healthcare, there's more money going into biotech research and development, and everyone's really focused on making sure there's enough food. Speaking of food, agriculture is a big deal for biotech in Africa. Think about ithuge potential for farms, but also tons of problems like droughts, diseases, and poor soil. Biotech companies are trying to fix this by creating new seed types, better fertilizers, and ways to control pests - all to boost harvests and make sure everyone gets enough to eat. So, yeah, it's early days for the African biotechnology industry, but expect big things! With the right funding and support, Africa could become a major player in the global biotech scene.

Key Players

The “Africa Pharmaceutical & Biotechnology Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Pfizer, Novartis AG, GlaxoSmithKline plc, Sanofi S.A, AstraZeneca, Abbott Laboratories, Biocon, Merck & Co., Inc., Cipla Inc., Gilead Sciences, Inc., Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd, Biogen, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Boehringer Ingelheim International GmbH, Eli Lilly, and Company, and Lonza.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We'll dive into the market using both numbers and deeper insights, breaking it down by segments based on everything from the economy to social trends. You'll get concrete market value figures (in USD Billion!) for each of these segments and sub-segments. Plus, we'll pinpoint the fastest-growing regions and segments, and which ones are set to be the biggest. Our geographical analysis will show you where products/services are really being used, and what's driving the market in each area. We'll map out the competitive scene, ranking the major players and covering recent launches, partnerships, expansions, and acquisitions from the last five years. Expect detailed company profiles with overviews, insights, product comparisons, and SWOT analyses for all the key players. We'll also give you the inside scoop on the industry's current and future, considering recent developments, growth opportunities, drivers, challenges, and restraints in both emerging and mature regions. We'll even use Porter's five forces to really dig into the market. Understand the VC and the market's inner workings. Finally, we'll explore the market's dynamics and upcoming growth opportunities. And don't forget – you'll get 6 months of analyst support after your purchase!

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.